“Clinical Lasting Response of Crizotinib in ALK Positive Lung Squamous Cell Carcinoma With Brain Metastasis”. European Journal of Oncology and Environmental Health, vol. 22, no. 2, Nov. 2017, pp. 95-97, https://mattioli1885journals.com/index.php/EJOEH/article/view/4800.